<DOC>
	<DOCNO>NCT02826616</DOCNO>
	<brief_summary>Giving preoperative loading dose 60mg trimetazidine safely effectively reduce PCI-related myocardial damage patient undergoing selective PCI . effect Trimetazidine primary PCI cardiac function patient ST-elevation myocardial infarction sure . study aim study effect Trimetazidine primary PCI cardiac function patient ST-elevation myocardial infarction .</brief_summary>
	<brief_title>Effect Trimetazidine During Primary PCI Cardiac Function Patients With ST-elevation Myocardial Infarction</brief_title>
	<detailed_description>Investigators enroll 240 patient STEMI admit Chinese PLA General Hospital Januay 2017 August 2017 . STEMI define typical chest pain last 30 min within previous 12 h , clear ST-segment elevation N0.1 mV ≥2 contiguous electrocardiographic lead , elevate blood level troponin T. We randomly assign eligible patient 1:1 ratio either 60mg trimetazidine oral placebo befor PCI . Trimetazidine group accept 20mg trimetazidine 12 month PCI active Comparator give placebo 12 month PCI . Primary end point study area viable myocardium come MR delay enhancement scan main cardiovascular event conclude recurrent myocardial infarction , cardiac death , recurrent angina , acute heart failure . Secondary end point study change LVEF . All adverse clinical event well study end point monitor adjudicated independent event committee . Each patient contact every week administration contrast , investigate main cardiovascular event ( myocardial infarction , acute heart failure death ) , record adverse event .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Trimetazidine</mesh_term>
	<criteria>STEMI patient : typical chest pain last 30 min within previous 12 h , clear STsegment elevation N0.1 mV ≥2 contiguous electrocardiographic lead , elevate blood level troponin T patient schedule undergo diagnostic cardiac angiography percutaneous coronary intervention The combine use trimetazidine contraindication ; cardiogenic shock , history myocardial infarction , stent thrombosis , renal insufficiency ; previously undergone coronary artery bypass surgery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Trimetazidine</keyword>
	<keyword>ST-segment elevation myocardial</keyword>
	<keyword>Reperfusion injury</keyword>
	<keyword>Percutaneous coronary intervention</keyword>
</DOC>